Long-Term Efficacy of 24-hour Subcutaneous Levodopa/Carbidopa Infusion (ND0612) for Motor Fluctuations in Parkinson's disease (PD)

被引：0
|
作者：
Espay, A.
Pahwa, R.
Ellenbogen, A.
Stocchi, F.
Giladi, N.
Salin, L.
Sasson, N.
Pereira, J.
Rascol, O.
机构：
来源：
MOVEMENT DISORDERS | 2024年 / 39卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
653
引用
收藏
页码：S301 / S301
页数：1
相关论文
共 50 条
  • [1] Impact of 24-hour Subcutaneous Levodopa/Carbidopa Infusion (ND0612) on Motor State Transitions Throughout the Day
    Ellenbogen, A.
    Ferreira, J.
    Stocchi, F.
    Kieburtz, K.
    Albanese, A.
    Adar, L.
    Vostokova, N.
    Pereira, J.
    Hauser, R.
    MOVEMENT DISORDERS, 2024, 39 : S312 - S313
  • [2] Efficacy of Continuous Subcutaneous Levodopa/Carbidopa Infusion (ND0612) on Motor Signs of Parkinson's disease (PD) and Experiences of Daily Living
    Rascol, O.
    Isaacson, S.
    LeWitt, P.
    Poewe, W.
    Ferreira, J.
    Lopes, N.
    Sopromadze, S.
    Pereira, J.
    Olanow, C.
    MOVEMENT DISORDERS, 2024, 39 : S313 - S313
  • [3] Pharmacokinetic profile of ND0612 (levodopa/carbidopa for subcutaneous infusion) in Parkinson's disease (PD) patients with motor fluctuations: results of a phase IIa dose finding study
    Giladi, N.
    Caraco, Y.
    Gurevich, T.
    Djaldetti, R.
    Cohen, Y.
    Yacobi-Zeevi, O.
    Oren, S.
    Kieburtz, K.
    Olanow, C. W.
    EUROPEAN JOURNAL OF NEUROLOGY, 2015, 22 : 66 - 66
  • [4] Dopaminergic Adverse Events With 24-hour Subcutaneous Infusion of ND0612
    Isaacson, S.
    Rascol, O.
    Sarva, H.
    Hauser, R.
    Stocchi, F.
    Lopes, N.
    Salin, L.
    Pereira, J.
    Giladi, N.
    MOVEMENT DISORDERS, 2024, 39 : S313 - S313
  • [5] Characterization of Infusion Site Reactions With 24-hour Subcutaneous Infusion of ND0612
    Poewe, W.
    Ellenbogen, A.
    Lopes, N.
    Pahwa, R.
    MOVEMENT DISORDERS, 2024, 39 : S306 - S306
  • [6] Characterization of Infusion Site Reactions With 24-hour Subcutaneous Infusion of ND0612
    Pahwa, Rajesh
    Ellenbogen, Aaron
    Lopes, Nelson
    Poewe, Werner
    ANNALS OF NEUROLOGY, 2024, 96 : S220 - S220
  • [7] CONTINUOUS SUBCUTANEOUS LEVODOPA/CARBIDOPA INFUSION (ND0612) FOR PATIENTS WITH PARKINSON'S DISEASE AND MOTOR FLUCTUATIONS: A PHASE 3, ACTIVE-CONTROLLED STUDY (BOUNDLESS)
    Stocchi, F.
    Espay, A.
    Albanese, A.
    Ellenbogen, A.
    Ferreira, J. J.
    Giladi, N.
    Gurevich, T.
    Hassin-Baer, S.
    Hernandez-Vara, J.
    Isaacson, S.
    Kieburtz, K.
    LeWitt, P.
    Lopez-Manzanares, L.
    Olanow, C. W.
    Pahwa, R.
    Poewe, W.
    Sarva, H.
    Yardeni, T.
    Adar, L.
    Lopes, N.
    Sasson, N.
    Case, R.
    Rascol, O.
    PARKINSONISM & RELATED DISORDERS, 2024, 122
  • [8] ND0612 (levodopa/carbidopa for subcutaneous infusion) in patients with Parkinson's disease and motor response fluctuations: A randomized, placebo-controlled phase 2 study
    Giladi, Nir
    Gurevich, Tanya
    Djaldetti, Ruth
    Adar, Liat
    Case, Ryan
    Leibman-Barak, Shelly
    Sasson, Nissim
    Caraco, Yoseph
    PARKINSONISM & RELATED DISORDERS, 2021, 91 : 139 - 145
  • [9] Efficacy of ND0612 a 24-hour Subcutaneous LevodopaCarbidopa Infusion for People with Parkinson's Disease Experiencing Motor Fluctuations: Subgroup-Analyses from a Randomized, Controlled Phase 3 Study
    Harrison, Antoinette
    Poewe, Werner
    Lopes, Nelson
    ANNALS OF NEUROLOGY, 2024, 96 : S219 - S220
  • [10] Long-term safety and efficacy of 24-hour levodopa-carbidopa intestinal gel in Parkinson's disease
    Morales-Briceno, Hugo
    Mahant, Neil
    Ha, Ainhi D.
    Chang, Florence C. F.
    Kim, Samuel D.
    Griffith, Jane
    Tsui, David
    Galea, Donna
    Fung, Victor S. C.
    MOVEMENT DISORDERS, 2019, 34 (11) : 1747 - 1748
12345